Pfizer (PFE) COVID, Cancer Drugs Key to Top-Line Growth
Our preview of the upcoming week's earnings reports include Pfizer (PFE), Advanced Micro Devices (AMD) and DraftKings (DKNG).
We're in the thick of first-quarter earnings season, and on this week's busy lineup is blue-chip drugmaker Pfizer (PFE, $49.34).
PFE shows up early on this week's earnings calendar, with the Big Pharma firm scheduled to unveil its first-quarter results ahead of Tuesday's open. Analysts are anticipating earnings of $1.48 per share, up 59% on a year-over-year (YoY) basis. Revenue is expected to arrive at $24.0 billion (+64.4% YoY).
Wall Street thinks Pfizer's COVID-19 regimens that include a vaccine co-developed with BioNTech (BNTX) and Paxlovid, its oral treatment granted regulatory approval last December, will contribute $12.5 billion to its top line, says Wells Fargo analyst Mohit Bansal.
From just $107.88 $24.99 for Kiplinger Personal Finance
Become a smarter, better informed investor. Subscribe from just $107.88 $24.99, plus get up to 4 Special Issues
Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
While Bansal expects PFE to fall a little short of this estimate, he anticipates a solid beat in the company's non-COVID business, with cancer drugs Ibrance and Inlyta "tracking ahead of consensus." The analyst has an Overweight rating (equivalent of Buy) on the Dow Jones stock.
And Bansal is in good company. Of the 23 analysts following the stock that are tracked by S&P Global Market Intelligence, eight say it's a Strong Buy, one calls it a Buy and 14 have it at Hold.
Advanced Micro Devices Stock Cheap Ahead of Earnings
Advanced Micro Devices (AMD, $87.93) has been hit hard with broad-market headwinds in 2022, down more than 38% for the year-to-date.
Can a solid earnings report give the semiconductor stock a jolt?
Raymond James analyst Chris Caso recently upgraded AMD to Strong Buy from Outperform. He believes Advanced Micro Devices is attractively valued, remaining well below its average forward price-to-earnings ratio of 40 over the last three and five years.
Caso admits a potential PC market slowdown and the sustainability of revenue growth for recently acquired Xilinx are concerns. However, "We have strong confidence regarding AMD's position and share gains in the datacenter market," the analyst says, with "tight supply conditions encouraging customers to commit to AMD to ensure supply."
Analysts are optimistic heading into AMD's Q1 2022 report. Consensus estimates are for Advanced Micro Devices to report earnings of 91 cents per share (+75% YoY) and revenue of $5.5 billion (+60.3% YoY).
DraftKings Q1 Revenue to Show Strong Growth
DraftKings (DKNG, $14.20) stock is down nearly 50% for the year-to-date, but Wall Street's pros are more bullish than not toward the online sports betting company. Of the 28 analysts following DKNG that are tracked by S&P Global Market Intelligence, 12 have it at Strong Buy, four call it a Buy and 12 believe it's a Hold.
Needham analyst Bernie McTernan is one of those with a Buy rating on DKNG, calling the company "a leader in the emerging North America online gambling market," with a $35 billion market opportunity.
Oppenheimer analyst Jed Kelly (Outperform) shares this sentiment, adding the company's "competencies in product development and customer acquisition" have helped it become a market leader. These will also play a key role in DKNG taking a roughly 25%-30% share of a quickly growing market as more states regulate online sports gambling (OSB).
In the near term, DraftKings "is acquiring players faster and more efficiently as OSB scales nationally (3.5% of Arizona adults in the first six months vs. New Jersey's 1.3%)," Kelly says.
As for DKNG's first-quarter earnings report – due out ahead of the May 6 open – analysts, on average, are looking for $414.4 million in revenue (+32.7% YoY) and a loss of $1.16 per share, wider than the 87 cents-per-share loss the company incurred in the year-ago period.
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.

With over a decade of experience writing about the stock market, Karee Venema is the senior investing editor at Kiplinger.com. She joined the publication in April 2021 after 10 years of working as an investing writer and columnist at a local investment research firm. In her previous role, Karee focused primarily on options trading, as well as technical, fundamental and sentiment analysis.
-
Is Your Emergency Fund Running Low? Here's How to Bulk It UpIf you're struggling right now, you're not alone. Here's how you can identify financial issues, implement a budget and prioritize rebuilding your emergency fund.
-
Guide to How All-Assets Planning Offers a Better RetirementAn "all-asset" strategy would integrate housing wealth and annuities with traditional investments to generate more income and liquid savings for retirees.
-
Forget FIRE: Why ‘FILE’ Is the Smarter Move for Child-Free DINKsHow shifting from "Retiring Early" to "Living Early" allows child-free adults to enjoy their wealth while they’re still young enough to use it.
-
If You'd Put $1,000 Into Lowe's Stock 20 Years Ago, Here's What You'd Have TodayLowe's stock has delivered disappointing returns recently, but it's been a great holding for truly patient investors.
-
If You'd Put $1,000 Into 3M Stock 20 Years Ago, Here's What You'd Have TodayMMM stock has been a pit of despair for truly long-term shareholders.
-
These Were the Hottest S&P 500 Stocks of the YearAI winners lead the list of the S&P 500's top 25 stocks of 2025, but some of the names might surprise you.
-
Stocks Chop as the Unemployment Rate Jumps: Stock Market TodayNovember job growth was stronger than expected, but sharp losses in October and a rising unemployment rate are worrying market participants.
-
If You'd Put $1,000 Into Coca-Cola Stock 20 Years Ago, Here's What You'd Have TodayEven with its reliable dividend growth and generous stock buybacks, Coca-Cola has underperformed the broad market in the long term.
-
If You Put $1,000 into Qualcomm Stock 20 Years Ago, Here's What You Would Have TodayQualcomm stock has been a big disappointment for truly long-term investors.
-
Dow Climbs 327 Points, Crosses 48,000: Stock Market TodayMarkets are pricing the end of the longest government shutdown in history – and another solid set of quarterly earnings.
-
Risk Is On Again, Dow Jumps 381 Points: Stock Market TodayThe stock market started the week strong on signs the government shutdown could soon be over.